The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases

Clinical Biochemistry

Volumn 38, Issue 6, 2005, Pages 531-534

  Horiike, Norio ^a   Abe, Masanori ^a   Kumagi, Teru ^a   Hiasa, Yoichi ^a   Akbar, S M Fazle ^a   Michitaka, Kojiro ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytochrome P 450 3A4; Hepatitis B virus; Hepatitis C virus; Viral liver diseases

Indexed keywords

CYTOCHROME P450 3A4; MESSENGER RNA;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS HEPATITIS; VIRUS TITRATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE PROGRESSION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 18844454489     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2005.01.005     Document Type: Article

References (23)

1. M. Eichelbaum, and O. Burk CYP3A genetics in drug metabolism Nat. Med. 7 2001 285 287
2. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F.P. Gengoich Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J. Pharmacol. Exp. Ther. 270 1994 414 423
3. V. Ozdemir, W. Kalown, and B.K. Tang Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method Pharmacogenetics 10 2000 373 388
4. M.C. Bastien, F. Leblond, and V. Pichette Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis Can. J. Physiol. Pharmacol. 78 2000 912 919
5. V.J. Desmet, M. Gerber, and J.H. Hoofnagle Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520
6. Liver Cancer Study Group of Japan The general rules for the clinical and pathological study of primary liver cancers Fourth ed. 2001 Kanehara Press Tokyo
7. N. Horiike, T. Nonaka, and I. Kumamoto Hepatitis C virus plus and minus strand RNA in hepatocellular carcinoma and adjoining nontumorous liver J. Med. Virol. 41 1993 312 315
8. A. Sumida, K. Kinoshita, and T. Fukuda Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver Biochem. Biophys. Res. Commun. 262 1999 499 503
9. R. Jover, R. Bort, M.J. Gomez-Lechon, and J.V. Castel Cytochrome P450 regulation by hepatocyte nuclear factor in human hepatocytes: a study using adenovirus-mediated antisense targeting Hepatology 33 2001 668 675
10. J.L. Raucy, E.D. Schults, and M.R. Wester Human lymphocyte cytochrome P4502E1, putative marker for alcohol mediated change in hepatic chlorzoxazone activity Drug Metab. Dispos. 25 1997 1429 1435
11. N. Finnstrom, M. Thorn, and L. Loof Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease Eur. J. Clin. Pharmacol. 57 2001 403 409
12. M. Emery, J. Fisher, and J. Chien CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease Hepatology 38 2003 428 435
13. N. Finnstrom, C. Bjelfman, M. Thorn, L. Loof, and F. Rane Quantification of cytochrome P450 mRNAs in patients with suspected liver diseases as assessed by reverse transcriptase-polymerase chain reaction J. Lab. Clin. Med. 134 1999 133 140
14. A. Sumida, S. Fukuen, I. Yamamoto, H. Matsuda, M. Naohara, and I. Azuma Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR Biochem. Biophys. Res. Commun. 267 2000 756 760
15. J.M. Pascussi, S. Gerbal-Chaloin, and L. Pichard-Garcia Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes Biochem. Biophys. Res. Commun. 11 2000 707 713
16. J. Genesca, A. Gonzaies, and R. Segura Interleukin-6, nitric oxide, ant the clinical and hemodynamic alterations of patients with liver cirrhosis Am. J. Gastroenterol. 94 1999 169 177
17. K. Nasu, T. Kubota, and T. Ishizaki Genetic analysis of CYP2C9 polymorphism in a Japanese population Pharmacogenetics 7 1997 405 409
18. Y. Tuneoka, K. Fukushima, Y. Matsuo, Y. Ichikawa, and Y. Watanabe Genotype analysis of the CYP2C19 gene in the Japanese population Life Sci. 59 1996 1711 1715
19. C.A. Fellix, A.H. Walker, and B.J. Lange Association of CYP3A4 genotype treatment-related leukemia Proc. Natl. Acad. Sci. 95 1998 13176 13181
20. T.R. Rebbeck, L.M. Jaffe, and A.H. Waiker Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J. Natl. Cancer Inst. 90 1998 1225 1229
21. A. Westlind, L. Lofberg, and N. Tindberg Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region Biochem. Biophys. Res. Commun. 27 1999 201 205
22. Y. Ando, T. Tateishi, and Y. Sekido Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J. Natl. Cancer Inst. 91 1999 1587 1588
23. N. Kondoh, T. Wakatsuki, and A. Ryo Identification and characterization of genes associated with human hepatocellular carcinogenesis Cancer Res. 59 1998 4990 4996